With the acquisition of Omnicare, CVS Health will significantly expand its ability to dispense prescriptions in assisted living and long term care facilities, serving the senior patient population. CVS Health will also expand its presence in the rapidly growing specialty pharmacy business.
The deal value (including assumption of debt) is $12.7B. The buyout price is a 6% premium to OCR’s closing price on 5/19/15.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”